Pharmaceutical company
CCL Pharmaceuticals
Pakistan
Represent this company?Verified companies can submit portfolio corrections, documents and approved company information.Claim / verify profile →
14products
10generics
0therapeutic areas
14current prices
Portfolio intelligence
Therapeutic mix
Unclassified 14
Company portfolio
14 resultsProducts
| Brand | Generic | Strength | Form | Pack | Registration | Current price |
|---|---|---|---|---|---|---|
| CYOTECAN | Irinotecan Hydrochloride Trihydrate | 40 mg | Injection | 2ml vial | 052286 | PKR 6,195.91 |
| CYTOTECAN | Irinotecan | 100 mg/5 mL | Injection | Per vial | 044847 | PKR 20,653.05 |
| DOXOCIN | Doxorubicin HCI | 10 mg | Injection | Per vial | 044844 | PKR 809.54 |
| DOXOCIN | Doxorubicin HCI | 50 mg | Injection | Per vial | 044845 | PKR 2,765.98 |
| LYMPHOSIDE | Etoposide | 100 mg | Injection | Per vial | 044846 | PKR 1,135.92 |
| MEBREXEL | Docetaxel | 80 mg | Injection | Per vial | 045606 | PKR 31,598.91 |
| MEBREXEL | Docetaxel | 20 mg | Injection | Per vial | 045608 | PKR 12,826.25 |
| METAPLAXEL | Paclitaxel (albumin-bound nanoparticles) | 30 mg/5 mL | Injection | Per vial | 044850 | PKR 6,122.53 |
| METAPLAXEL | Paclitaxel | 150 mg/25 mL | Injection | Per vial | 045713 | PKR 25,196.71 |
| ONCOPLATIN | Cisplatin | 50 mg | Injection | Per vial | 044843 | PKR 2,575.44 |
| TOXIPLATIN | Carboplatin | 450 mg | Injection | Per vial | 044852 | PKR 9,190.61 |
| TOXIPLATIN | Carboplatin | 150 mg | Injection | Per vial | 044851 | PKR 4,595.30 |
| XALIPLATIN | Oxaliplatin | 50 mg | Injection | Per vial | 044848 | PKR 20,215.87 |
| XALIPLATIN | Oxaliplatin | 100 mg | Injection | Per vial | 044849 | PKR 40,431.74 |